Mounjaro Side Effects & Diet: Hannah’s Experience with Weight Loss

A woman in Bournemouth, Dorset, is sharing her experience with Mounjaro, a weight-loss medication, and its impact on managing symptoms of polycystic ovary syndrome (PCOS). Hannah Kate, 32, began using the medication in May 2024, after struggling with weight loss for years, and has reported significant improvements in her confidence and overall well-being. Her story highlights a growing area of interest in the potential off-label use of weight-loss drugs for conditions like PCOS, which affects up to one in ten women in the UK.

Understanding PCOS and Insulin Resistance

Polycystic ovary syndrome is a hormonal disorder characterized by irregular periods, and often, painful periods. A key driver of PCOS symptoms is insulin resistance, a condition where the body’s cells don’t respond effectively to insulin, leading to higher blood sugar levels. This connection is why weight-loss medications, like Mounjaro, are being explored as potential therapeutic options. Mounjaro, and similar drugs, work by mimicking a natural hormone that regulates appetite and insulin secretion. By improving insulin sensitivity, these medications may help manage the hormonal imbalances associated with PCOS. However, it’s important to note that these jabs are not currently licensed for use on the NHS specifically for PCOS. current recommendations focus on lifestyle changes and other medications. The BBC reports on this emerging trend.

Hannah’s Journey with Mounjaro

Hannah Kate has spent approximately £4,000 on Mounjaro, purchasing it from a licensed provider. She has seen a substantial change in her body size, dropping from a size 26 to a 16-18. Beyond the physical changes, she emphasizes the positive impact on her self-esteem. “It made me perceive so self-conscious because I could never locate anything in clothes shops that fit me,” she said. “The fact that I can now go into pretty much any shop and buy something really is the best feeling.”

While the results have been positive, Hannah acknowledges experiencing side effects. She describes them as feeling “like a hangover,” with symptoms including sickness, constipation, and headaches. She manages these side effects by adjusting her diet, a strategy that has proven helpful. Interestingly, she hasn’t experienced significant appetite suppression, except at higher doses of the medication. However, she notes that “the insulin resistance was being controlled,” which has been the primary benefit.

Dietary Adjustments and Managing Side Effects

Hannah’s dietary approach focuses on a high-protein intake. Her typical breakfast consists of Greek yogurt and fruit, while lunch and dinner feature chicken or fish. She avoids red meat. She also incorporates intuitive eating alongside calorie tracking, allowing herself one less-nutritious, but low-calorie, treat each day. This balanced approach appears to be key to mitigating the side effects of Mounjaro. AOL News also details Hannah’s dietary adjustments.

The Role of Metformin and Alternative Treatments

Prior to starting Mounjaro, Hannah was prescribed Metformin by the NHS. Metformin is a medication commonly used to treat type 2 diabetes and can also be used to improve insulin sensitivity in women with PCOS. If Hannah had chosen not to pursue Mounjaro, she would have continued with the tier three NHS weight management program. The use of Mounjaro, however, represents an “off-label” application, meaning it’s being used for a purpose not specifically approved by regulators. This practice isn’t uncommon when a medication shows promise for a condition beyond its licensed indication, but it’s important to be aware of the potential risks and benefits.

What the Experts Say About Weight-Loss Jabs and PCOS

Experts suggest that weight-loss jabs may be beneficial for individuals with PCOS due to their ability to improve insulin resistance. Insulin resistance is a central feature of PCOS, contributing to many of its symptoms. By addressing this underlying issue, these medications may help regulate menstrual cycles, improve fertility, and reduce other PCOS-related health concerns. However, further research is needed to fully understand the long-term effects and optimal use of these medications in the context of PCOS. The NHS currently recommends lifestyle changes and other medications as the first-line treatment for PCOS.

Looking Ahead: Research and Guidance Updates

The growing interest in using weight-loss medications for PCOS is likely to drive further research in this area. Clinical trials are needed to evaluate the efficacy and safety of these medications specifically for PCOS, and to determine the optimal dosage and duration of treatment. Health authorities, like the National Institute for Health and Care Excellence (NICE) in the UK, will likely review the emerging evidence and update their guidance accordingly. It’s also important to monitor for any potential long-term side effects and to develop strategies for managing them effectively. The current situation underscores the necessitate for a personalized approach to PCOS management, with treatment plans tailored to the individual’s specific needs and circumstances.

For individuals considering weight-loss medications for PCOS, it’s crucial to have a thorough discussion with a qualified healthcare professional. They can assess your individual risk factors, explain the potential benefits and risks, and help you produce an informed decision about the best course of treatment. Staying informed about the latest research and guidance updates is also essential.